Home › Employers › Syndax Pharmaceuticals, Inc
Syndax Pharmaceuticals, Inc: H-1B salaries and sponsorship
Syndax Pharmaceuticals, Inc filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $197,600.
Does Syndax Pharmaceuticals, Inc sponsor H-1B visas?
Syndax Pharmaceuticals, Inc filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 13, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Principal Statistical Programmer | 2 | $188,800 |
| Director, IT R&D Technology Platforms and Operations | 1 | $220,000 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $180,000 |
| FY2026 | 2 | $208,800 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Director, IT R&D Technology Platforms and Operations | $220,000 Level IV | Fuquay Varina, NC | Apr 13, 2026 | Apr 20, 2026 | Certified |
| Principal Statistical Programmer | $197,600 Level IV | New York, NY | Feb 21, 2026 | Aug 21, 2026 | Certified |
| Principal Statistical Programmer | $180,000 Level IV | Waltham, MA | Aug 4, 2023 | Aug 21, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).